Trial · NCT04004754
Outcomes of Complicated CL in Ethiopia Treated With Miltefosine
NCT04004754, Completed, Institute of Tropical Medicine, Belgium
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Outcomes of Complicated CL in Ethiopia Treated With Miltefosine. Trials, record NCT04004754. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04004754
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Outcomes of Complicated CL in Ethiopia Treated With Miltefosine
- NCT number
- NCT04004754
- Status
- Completed
- Enrollment
- 94 participants, actual
- Lead sponsor
- Institute of Tropical Medicine, Belgium
- Conditions
- Cutaneous Leishmaniases
- Interventions
- Miltefosine (administration is not part of study procedures)
- First posted
- 2019-07-02
- Last updated
- 2020-06-25
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Assess final treatment response | Day 90 | proportion of index lesions with cure, good, partial and no treatment response |
| Secondary | Early and late treatment response | Day 28, Day 180 | Proportion of index lesions with cure, good, partial and no treatment response at Day 28 and Day 180 |
| Secondary | Treatment failure | Day 90, Day 180 | Proportion of index lesions with relapse or failure at Day 90 and Day 180 |
| Secondary | Adherence | Day 28 | Proportion of patients with excellent (0 missed), good (1-3 missed), mediocre (4-8 missed), and poor (\<=9 missed) adherence |
| Secondary | Predictors of cure | Day 90 | Covariate-adjusted risk ratios of factors associated with cure of index lesions at Day 90 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 34048461 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04004754
GET https://conductscience.org/api/trials/v1/NCT04004754/registered